Loading...
Header Logo
Keywords
Last Name
Institution

Joud Hajjar

TitleAssistant Professor
InstitutionBaylor College of Medicine
DepartmentDepartment of Pediatrics
DivisionPediatrics-Immu, Allergy & Retrovir
vCardDownload vCard
    Other Positions
    TitleGraduate Student
    InstitutionBaylor College of Medicine
    DepartmentClinical Scientist Training Program (PhD)


    Collapse ORNG Applications 
    Collapse Websites
    Collapse Aliases
    Collapse Verify Publications

    Collapse Biography 
    Collapse awards and honors
    2016The US Immunodeficiency Network travel grant
    2016 - 2019The US Immunodeficiency Network research award
    2016 - 2019The Immunodeficiency Foundation research award
    2018The Clinical immmunology scoiety travel grant
    2018The US Immunodeficiency Network travel grant
    2018 - 2019The Chao Physician Scientist award
    2018 - 2019The Jeffrey Modell Foundation
    2019TX TopDocs
    2019Castle Connolly’s Exceptional Women in Medicine
    2019Castle Connolly’s Top Doctor

    Collapse Overview 

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Naing A, Meric-Bernstam F, Stephen B, Karp DD, Hajjar J, Rodon Ahnert J, Piha-Paul SA, Colen RR, Jimenez C, Raghav KP, Ferrarotto R, Tu SM, Campbell M, Wang L, Sabir SH, Tapia C, Bernatchez C, Frumovitz M, Tannir N, Ravi V, Khan S, Painter JM, Abonofal A, Gong J, Alshawa A, McQuinn LM, Xu M, Ahmed S, Subbiah V, Hong DS, Pant S, Yap TA, Tsimberidou AM, Dumbrava EEI, Janku F, Fu S, Simon RM, Hess KR, Varadhachary GR, Amir Habra M. Phase 2 study of pembrolizumab in patients with advanced rare cancers. J Immunother Cancer. 2020 Mar; 8(1). PMID: 32188704.
      View in: PubMed
    2. Nguyen AL, Constantine G, Kutac C, Syed MN, Orange JS, Sullivan KE. Prophylactic Antibiotics Versus Immunoglobulin Replacement in Specific Antibody Deficiency. J Clin Immunol. 2020 Jan; 40(1):158-164. PMID: 31758281.
      View in: PubMed
    3. Chinn IK, Chan AY, Chen K, Chou J, Dorsey MJ, Hajjar J, Jongco AM, Keller MD, Kobrynski LJ, Kumanovics A, Lawrence MG, Leiding JW, Lugar PL, Orange JS, Patel K, Platt CD, Puck JM, Raje N, Romberg N, Slack MA, Sullivan KE, Tarrant TK, Torgerson TR, Walter JE. Diagnostic interpretation of genetic studies in patients with primary immunodeficiency diseases: A working group report of the Primary Immunodeficiency Diseases Committee of the American Academy of Allergy, Asthma & Immunology. J Allergy Clin Immunol. 2020 Jan; 145(1):46-69. PMID: 31568798.
      View in: PubMed
    4. Noroski L, Das S, Hajjar J. Case 40-2018: A Woman with Recurrent Sinusitis, Cough, and Bronchiectasis. N Engl J Med. 2019 04 04; 380(14):1383. PMID: 30943358.
      View in: PubMed
    5. Hajjar J, Kutac C, Rider NL, Seeborg FO, Scalchunes C, Orange J. Fatigue and the wear-off effect in adult patients with common variable immunodeficiency. Clin Exp Immunol. 2018 12; 194(3):327-338. PMID: 30168848.
      View in: PubMed
    6. Tuano KTS, Anvari S, Hanson IC, Hajjar J, Seeborg F, Noroski LM, Guffey D, Kang G, Orange JS, Davis CM. Improved diagnostic clarity in shrimp allergic non-dust-mite sensitized patients. Allergy Asthma Proc. 2018 Sep 01; 39(5):377-383. PMID: 30153888.
      View in: PubMed
    7. Fujii T, Naing A, Rolfo C, Hajjar J. Biomarkers of response to immune checkpoint blockade in cancer treatment. Crit Rev Oncol Hematol. 2018 Oct; 130:108-120. PMID: 30196907.
      View in: PubMed
    8. Hajjar J, Al-Kaabi A, Kutac C, Dunn J, Shearer WT, Orange JS. Questioning the accuracy of currently available pneumococcal antibody testing. J Allergy Clin Immunol. 2018 10; 142(4):1358-1360. PMID: 29936105.
      View in: PubMed
    9. Heimall JR, Hagin D, Hajjar J, Henrickson SE, Hernandez-Trujillo HS, Itan Y, Kobrynski L, Paris K, Torgerson TR, Verbsky JW, Wasserman RL, Hsieh EWY, Bleesing JJ, Chou JS, Lawrence MG, Marsh RA, Rosenzweig SD, Orange JS, Abraham RS. Correction to: Use of Genetic Testing for Primary Immunodeficiency Patients. J Clin Immunol. 2018 May; 38(4):540-541. PMID: 29781065.
      View in: PubMed
    10. Jeff Stonebraker, Joud Hajjar, and Jordan S. Orange. Latent therapeutic demand model for the immunoglobulin replacement therapy of primary immune deficiency disorders in the USA. Latent therapeutic demand model for the immunoglobulin replacement therapy of primary immune deficiency disorders in the USA. 2018.
    11. Heimall JR, Hagin D, Hajjar J, Henrickson SE, Hernandez-Trujillo HS, Tan Y, Kobrynski L, Paris K, Torgerson TR, Verbsky JW, Wasserman RL, Hsieh EWY, Blessing JJ, Chou JS, Lawrence MG, Marsh RA, Rosenzweig SD, Orange JS, Abraham RS. Use of Genetic Testing for Primary Immunodeficiency Patients. J Clin Immunol. 2018 04; 38(3):320-329. PMID: 29675737.
      View in: PubMed
    12. Stephen B, Hajjar J. Overview of Basic Immunology and Translational Relevance for Clinical Investigators. Adv Exp Med Biol. 2018; 995:1-41. PMID: 30539504.
      View in: PubMed
    13. Fujii T, Colen RR, Bilen MA, Hess KR, Hajjar J, Suarez-Almazor ME, Alshawa A, Hong DS, Tsimberidou A, Janku F, Gong J, Stephen B, Subbiah V, Piha-Paul SA, Fu S, Sharma P, Mendoza T, Patel A, Thirumurthi S, Sheshadri A, Meric-Bernstam F, Naing A. Incidence of immune-related adverse events and its association with treatment outcomes: the MD Anderson Cancer Center experience. Invest New Drugs. 2018 08; 36(4):638-646. PMID: 29159766.
      View in: PubMed
    14. Colen RR, Fujii T, Bilen MA, Kotrotsou A, Abrol S, Hess KR, Hajjar J, Suarez-Almazor ME, Alshawa A, Hong DS, Giniebra-Camejo D, Stephen B, Subbiah V, Sheshadri A, Mendoza T, Fu S, Sharma P, Meric-Bernstam F, Naing A. Radiomics to predict immunotherapy-induced pneumonitis: proof of concept. Invest New Drugs. 2018 08; 36(4):601-607. PMID: 29075985.
      View in: PubMed
    15. Hajjar J, Restrepo A, Javeri H, Wiederhold NP, Papanastassiou AM, Patterson TF. Multiple Brain Abscesses Caused by Trichosporon inkin in a Patient with X-Linked Chronic Granulomatous Disease (CGD) Successfully Treated with Antifungal Therapy. J Clin Immunol. 2017 08; 37(6):519-523. PMID: 28698914.
      View in: PubMed
    16. Rider NL, Kutac C, Hajjar J, Scalchunes C, Seeborg FO, Boyle M, Orange JS. Health-Related Quality of Life in Adult Patients with Common Variable Immunodeficiency Disorders and Impact of Treatment. J Clin Immunol. 2017 Jul; 37(5):461-475. PMID: 28536745.
      View in: PubMed
    17. Hajjar J, Guffey D, Minard CG, Orange JS. Increased Incidence of Fatigue in Patients with Primary Immunodeficiency Disorders: Prevalence and Associations Within the US Immunodeficiency Network Registry. J Clin Immunol. 2017 Feb; 37(2):153-165. PMID: 28124237.
      View in: PubMed
    18. Stephen B, Hajjar J. Overview of Basic Immunology for Clinical Investigators. Adv Exp Med Biol. 2017; 995:1-31. PMID: 28321810.
      View in: PubMed
    19. Bupathi M, Hajjar J, Bean S, Fu S, Hong D, Karp D, Stephen B, Hess K, Meric-Bernstam F, Naing A. Incidence of infusion reactions to anti-neoplastic agents in early phase clinical trials: The MD Anderson Cancer Center experience. Invest New Drugs. 2017 02; 35(1):59-67. PMID: 27687047.
      View in: PubMed
    20. Hajjar J, Hasan S, Forbes LR, Hemmige V, Orange JS. Gastric Adenocarcinoma in a Patient with X-Linked Agammaglobulinemia and HIV: Case Report and Review of the Literature. Front Pediatr. 2016; 4:100. PMID: 27722150.
      View in: PubMed
    21. Quinti I, Pulvirenti F, Giannantoni P, Hajjar J, Canter DL, Milito C, Abeni D, Orange JS, Tabolli S. Development and Initial Validation of a Questionnaire to Measure Health-Related Quality of Life of Adults with Common Variable Immune Deficiency: The CVID_QoL Questionnaire. J Allergy Clin Immunol Pract. 2016 Nov - Dec; 4(6):1169-1179.e4. PMID: 27665385.
      View in: PubMed
    22. Moon YW, Hajjar J, Hwu P, Naing A. Targeting the indoleamine 2,3-dioxygenase pathway in cancer. J Immunother Cancer. 2015; 3:51. PMID: 26674411.
      View in: PubMed
    23. Hajjar J, Habra MA, Naing A. Metformin: an old drug with new potential. Expert Opin Investig Drugs. 2013 Dec; 22(12):1511-7. PMID: 23978196.
      View in: PubMed
    24. Najm S, Hajjar J, Nelson RP, Moorthy RS, Wolf KM, Lahm T. Whipple's disease-associated pulmonary hypertension with positive vasodilator response despite severe hemodynamic derangements. Can Respir J. 2011 Sep-Oct; 18(5):e70-2. PMID: 21969933.
      View in: PubMed
    25. Petrache I, Hajjar J, Campos M. Safety and efficacy of alpha-1-antitrypsin augmentation therapy in the treatment of patients with alpha-1-antitrypsin deficiency. Biologics. 2009; 3:193-204. PMID: 19707408.
      View in: PubMed
    Hajjar's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description